MEN1 and multiple endocrine neoplasia type 1: Patients with the multiple endocrine neoplasia type 1 (MEN1) syndrome carry a heterozygous germline inactivating mutation in MEN1 that predisposes to tumors of multiple endocrine and nonendocrine tissues (OMIM ID 131100 and 613733) [1–3].